vicarious surgical inc - RBOT

RBOT

Close Chg Chg %
2.00 -0.07 -3.50%

Closed Market

1.93

-0.07 (3.50%)

Volume: 53.79K

Last Updated:

Mar 2, 2026, 3:59 PM EDT

Company Overview: vicarious surgical inc - RBOT

RBOT Key Data

Open

$2.02

Day Range

1.93 - 2.08

52 Week Range

1.72 - 13.75

Market Cap

$4.92M

Shares Outstanding

7.12M

Public Float

5.40M

Beta

1.77

Rev. Per Employee

N/A

P/E Ratio

N/A

EPS

-$6.68

Yield

0.00%

Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

68.66K

 

RBOT Performance

No Data Available

RBOT Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 1
Full Ratings ➔

About vicarious surgical inc - RBOT

Vicarious Surgical, Inc. a blank check company, which engages in effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. It also designs surgical robotics. The company was founded by Adam Sachs, Sammy Khalifa, and Barry Greene on May 1, 2014 and is headquartered in Waltham, MA.

RBOT At a Glance

Vicarious Surgical, Inc.
78 Fourth Avenue
Waltham, Massachusetts 02451
Phone 1-617-868-1700 Revenue 0.00
Industry Medical Specialties Net Income -50,182,000.00
Sector Health Technology Employees 26
Fiscal Year-end 12 / 2026
View SEC Filings

RBOT Valuation

P/E Current N/A
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) N/A
Price to Sales Ratio N/A
Price to Book Ratio 1.569
Price to Cash Flow Ratio N/A
Enterprise Value to EBITDA -0.228
Enterprise Value to Sales N/A
Total Debt to Enterprise Value 0.689

RBOT Efficiency

Revenue/Employee N/A
Income Per Employee -1,930,076.923
Receivables Turnover N/A
Total Asset Turnover N/A

RBOT Liquidity

Current Ratio 2.967
Quick Ratio 2.967
Cash Ratio 2.508

RBOT Profitability

Gross Margin N/A
Operating Margin N/A
Pretax Margin N/A
Net Margin N/A
Return on Assets -114.964
Return on Equity -177.513
Return on Total Capital -284.624
Return on Invested Capital -133.922

RBOT Capital Structure

Total Debt to Total Equity 79.159
Total Debt to Total Capital 44.184
Total Debt to Total Assets 39.783
Long-Term Debt to Equity 59.303
Long-Term Debt to Total Capital 33.101
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Vicarious Surgical Inc - RBOT

Collapse All in section
All values USD millions. 2022 2023 2024 2025 5-year trend
Sales/Revenue
- - - -
-
Sales Growth
- - - -
-
Cost of Goods Sold (COGS) incl D&A
1.94M 1.85M 2.11M 1.43M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
1.94M 1.85M 2.11M 1.43M
Depreciation
1.94M 1.85M 2.11M 1.43M
Amortization of Intangibles
- - - -
-
COGS Growth
+513.92% -4.43% +13.65% -32.37%
Gross Income
(1.94M) (1.85M) (2.11M) (1.43M)
Gross Income Growth
-513.92% +4.43% -13.65% +32.37%
Gross Profit Margin
- - - -
-
2022 2023 2024 2025 5-year trend
SG&A Expense
78.14M 78.81M 64.45M 49.54M
Research & Development
41.96M 45.72M 38.05M 32.18M
Other SG&A
36.18M 33.09M 26.40M 17.37M
SGA Growth
+106.13% +0.86% -18.23% -23.13%
Other Operating Expense
- - - -
-
Unusual Expense
(84.00M) (5.19M) (43.00K) (1.73M)
EBIT after Unusual Expense
3.92M (75.47M) (66.51M) (49.24M)
Non Operating Income/Expense
1.44M 4.43M 3.29M (942.00K)
Non-Operating Interest Income
1.44M 4.43M 3.29M 973.00K
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
- - 200.00K 25.00K
-
Interest Expense Growth
- +124.72% -87.50% -100.00%
Gross Interest Expense
- - 200.00K 25.00K
-
Interest Capitalized
- - - -
-
Pretax Income
5.16M (71.07M) (63.22M) (50.18M)
Pretax Income Growth
+114.65% -1,478.15% +11.04% +20.63%
Pretax Margin
- - - -
-
Income Tax
- - - -
-
Income Tax - Current - Domestic
- - - -
-
Income Tax - Current - Foreign
- - - -
-
Income Tax - Deferred - Domestic
- - - -
-
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
5.16M (71.07M) (63.22M) (50.18M)
Minority Interest Expense
- - - -
-
Net Income
5.16M (71.07M) (63.22M) (50.18M)
Net Income Growth
+114.65% -1,478.15% +11.04% +20.63%
Net Margin Growth
- - - -
-
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
5.16M (71.07M) (63.22M) (50.18M)
Preferred Dividends
- - - -
-
Net Income Available to Common
5.16M (71.07M) (63.22M) (50.18M)
EPS (Basic)
1.2702 -14.6031 -10.742 -8.1854
EPS (Basic) Growth
+111.63% -1,249.67% +26.44% +23.80%
Basic Shares Outstanding
4.06M 4.87M 5.89M 6.13M
EPS (Diluted)
1.2132 -14.6031 -10.742 -8.1854
EPS (Diluted) Growth
+111.11% -1,303.68% +26.44% +23.80%
Diluted Shares Outstanding
4.25M 4.87M 5.89M 6.13M
EBITDA
(78.14M) (78.81M) (64.45M) (49.54M)
EBITDA Growth
-106.13% -0.86% +18.23% +23.13%
EBITDA Margin
- - - -
-

Snapshot

Average Recommendation HOLD Average Target Price 5.00
Number of Ratings 1 Current Quarters Estimate N/A
FY Report Date N/A Current Year's Estimate N/A
Last Quarter’s Earnings -1.03 Median PE on CY Estimate N/A
Year Ago Earnings -8.31 Next Fiscal Year Estimate N/A
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates N/A N/A N/A N/A
Mean Estimate N/A N/A N/A N/A
High Estimates N/A N/A N/A N/A
Low Estimate N/A N/A N/A N/A
Coefficient of Variance N/A N/A N/A N/A

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 0 0 0
OVERWEIGHT 0 0 0
HOLD 1 1 1
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Hold Hold Hold

Insider Actions for Vicarious Surgical Inc - RBOT

Date Name Shares Transaction Value
Jun 5, 2025 Sammy Khalifa Chief Technology Officer; Director 35,630 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $7.25 per share 258,317.50
Jun 5, 2025 Adam Sachs CEO; Director 50,723 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $7.22 per share 366,220.06

Vicarious Surgical Inc in the News